3D-QSAR and molecular docking studies of azaindole derivatives as Aurora B kinase inhibitors

被引:10
作者
Lan, Ping [1 ]
Chen, Wan-Na [1 ]
Sun, Ping-Hua [1 ]
Chen, Wei-Min [1 ]
机构
[1] Jinan Univ, Coll Pharm, Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou 510632, Guangdong, Peoples R China
关键词
3D-QSAR; CoMFA; CoMSIA; Molecular docking; Aurora kinase B; DISCOVERY; POTENT; SERIES; COMFA; EXPLORATION; SAR;
D O I
10.1007/s00894-010-0820-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Aurora kinases have been regarded as attractive targets for the development of new anticancer agents. Recently a series of azaindole derivatives with Aurora B inhibitory activities were reported. To explore the relationship between the structures of substituted azaindole derivatives and their inhibition of Aurora B, 3D-QSAR and molecular docking studies were performed on a dataset of 41 compounds. 3D-QSAR, including CoMFA and CoMSIA, were applied to identify the key structures impacting their inhibitory potencies. The CoMSIA model showed better results than CoMFA, with r (2) (cv) value of 0.575 and r (2) value of 0.987. 3D contour maps generated from CoMFA and CoMSIA along with the docking binding structures provided enough information about the structural requirements for better activity. Based on the structure-activity relationship revealed by the present study, we have designed a set of novel Aurora B inhibitors that showed excellent potencies in the developed models. Thus, our results allowed us to design new derivatives with desired activities.
引用
收藏
页码:1191 / 1205
页数:15
相关论文
共 28 条
[1]   Discovery of GSK1070916, a Potent and Selective Inhibitor of Aurora B/C Kinase [J].
Adams, Nicholas D. ;
Adams, Jerry L. ;
Burgess, Joelle L. ;
Chaudhari, Amita M. ;
Copeland, Robert A. ;
Donatelli, Carla A. ;
Drewry, David H. ;
Fisher, Kelly E. ;
Hamajima, Toshihiro ;
Hardwicke, Mary Ann ;
Huffman, William F. ;
Koretke-Brown, Kristin K. ;
Lai, Zhihong V. ;
McDonald, Octerloney B. ;
Nakamura, Hiroko ;
Newlander, Ken A. ;
Oleykowski, Catherine A. ;
Parrish, Cynthia A. ;
Patrick, Denis R. ;
Plant, Ramona ;
Sarpong, Martha A. ;
Sasaki, Kosuke ;
Schmidt, Stanley J. ;
Silva, Domingos J. ;
Sutton, David ;
Tang, Jun ;
Thompson, Christine S. ;
Tummino, Peter J. ;
Wang, Jamin C. ;
Xiang, Hong ;
Yang, Jingsong ;
Dhanak, Dashyant .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (10) :3973-4001
[2]   The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma [J].
Aihara, Arihiro ;
Tanaka, Shinji ;
Yasen, Mahmut ;
Matsumura, Satoshi ;
Mitsunori, Yusuke ;
Murakata, Ayano ;
Noguchi, Norio ;
Kudo, Atsushi ;
Nakamura, Noriaki ;
Ito, Koji ;
Arii, Shigeki .
JOURNAL OF HEPATOLOGY, 2010, 52 (01) :63-71
[3]   Hit generation and exploration:: Imidazo[4,5-b] pyridine derivatives as inhibitors of Aurora kinases [J].
Bavetsias, Vassilios ;
Sun, Chongbo ;
Bouloc, Nathalie ;
Reynisson, Johannes ;
Workman, Paul ;
Linardopoulos, Spiros ;
McDonald, Edward .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (23) :6567-6571
[4]   The discovery of the potent aurora inhibitor MK-0457 (VX-680) [J].
Bebbington, David ;
Binch, Hayley ;
Charrier, Jean-Damien ;
Everitt, Simon ;
Fraysse, Damien ;
Golec, Julian ;
Kay, David ;
Knegtel, Ronald ;
Mak, Chau ;
Mazzei, Francesca ;
Miller, Andrew ;
Mortimore, Michael ;
O'Donnell, Michael ;
Patel, Sanjay ;
Pierard, Francoise ;
Pinder, Joanne ;
Pollard, John ;
Ramaya, Sharn ;
Robinson, Daniel ;
Rutherford, Alistair ;
Studley, John ;
Westcott, James .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (13) :3586-3592
[5]   CoMFA and CoMSIA analyses on 4-oxo-1,4-dihydroquinoline and 4-oxo-1,4-dihydro-1,5-,-1,6-and-1,8-naphthyridine derivatives as selective CB2 receptor agonists [J].
Cichero, Elena ;
Cesarini, Sara ;
Mosti, Luisa ;
Fossa, Paola .
JOURNAL OF MOLECULAR MODELING, 2010, 16 (04) :677-691
[6]   Aurora kinase A inhibitors:: Identification, SAR exploration and molecular modeling of 6,7-dihydro-4H-pyrazolo-[1,5-a]pyrrolo[3,4-d]pyrimidine-5,8-dione scaffold [J].
Coumar, Mohane Selvaraj ;
Wu, Jian-Sung ;
Leou, Jiun-Shyang ;
Tan, Uan-Kang ;
Chang, Chung-Yu ;
Chang, Teng-Yuan ;
Lin, Wen-Hsing ;
Hsu, John T. -A. ;
Chao, Yu-Sheng ;
Wu, Su-Ying ;
Hsieh, Hsing-Pang .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (05) :1623-1627
[7]   Synthesis and SAR of 1-acetanilide-4-aminopyrazole-substituted quinazolines: Selective inhibitors of Aurora B kinase with potent anti-tumor activity [J].
Foote, Kevin M. ;
Mortlock, Andrew A. ;
Heron, Nicola M. ;
Jung, Frederic H. ;
Hill, George B. ;
Pasquet, Georges ;
Brady, Madeleine C. ;
Green, Stephen ;
Heaton, Simon P. ;
Kearney, Sarah ;
Keen, Nicholas J. ;
Odedra, Rajesh ;
Wedge, Stephen R. ;
Wilkinson, Robert W. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (06) :1904-1909
[8]   Fragment-Based Discovery of the Pyrazol-4-yl Urea (AT9283), a Multitargeted Kinase Inhibitor with Potent Aurora Kinase Activity [J].
Howard, Steven ;
Berdini, Valerio ;
Boulstridge, John A. ;
Carr, Maria G. ;
Cross, David M. ;
Curry, Jayne ;
Devine, Lindsay A. ;
Early, Theresa R. ;
Fazal, Lynsey ;
Gill, Adrian L. ;
Heathcote, Michelle ;
Maman, Sarita ;
Matthews, Julia E. ;
McMenamin, Rachel L. ;
Navarro, Eva F. ;
O'Brien, Michael A. ;
O'Reilly, Marc ;
Rees, David C. ;
Reule, Matthias ;
Tisi, Dominic ;
Williams, Glyn ;
Vinkovic, Mladen ;
Wyatt, Paul G. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (02) :379-388
[9]   Receptor- and ligand-based 3D-QSAR study for a series of non-nucleoside HIV-1 reverse transcriptase inhibitors [J].
Hu, Rongjing ;
Barbault, Florent ;
Delamar, Michel ;
Zhang, Ruisheng .
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (06) :2400-2409
[10]   Design, synthesis, and biological evaluation of novel pyrimidine derivatives as CDK2 inhibitors [J].
Ibrahim, Diaa A. ;
El-Metwally, Amira M. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (03) :1158-1166